vs
Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and EMERSON RADIO CORP (MSN). Click either name above to swap in a different company.
EMERSON RADIO CORP is the larger business by last-quarter revenue ($1.9M vs $1.6M, roughly 1.2× bioAffinity Technologies, Inc.). EMERSON RADIO CORP runs the higher net margin — -36.7% vs -197.0%, a 160.3% gap on every dollar of revenue. On growth, bioAffinity Technologies, Inc. posted the faster year-over-year revenue change (-27.8% vs -52.8%). Over the past eight quarters, EMERSON RADIO CORP's revenue compounded faster (-7.3% CAGR vs -18.6%).
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.
BIAF vs MSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $1.9M |
| Net Profit | $-3.1M | $-694.0K |
| Gross Margin | — | 10.9% |
| Operating Margin | -196.9% | -43.7% |
| Net Margin | -197.0% | -36.7% |
| Revenue YoY | -27.8% | -52.8% |
| Net Profit YoY | -5.7% | -31.7% |
| EPS (diluted) | $-3.59 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $1.9M | ||
| Q3 25 | $1.4M | $1.2M | ||
| Q2 25 | $1.3M | $1.7M | ||
| Q1 25 | $1.9M | $1.8M | ||
| Q4 24 | $2.2M | $4.0M | ||
| Q3 24 | $2.4M | $2.7M | ||
| Q2 24 | $2.4M | $2.2M | ||
| Q1 24 | $2.4M | $2.2M |
| Q4 25 | $-3.1M | $-694.0K | ||
| Q3 25 | $-5.1M | $-1.0M | ||
| Q2 25 | $-4.1M | $-1.1M | ||
| Q1 25 | $-2.7M | $-2.4M | ||
| Q4 24 | $-3.0M | $-527.0K | ||
| Q3 24 | $-2.0M | $-881.0K | ||
| Q2 24 | $-2.1M | $-962.0K | ||
| Q1 24 | $-2.0M | $-883.0K |
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | -0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | — | 12.3% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | — | 15.9% |
| Q4 25 | -196.9% | -43.7% | ||
| Q3 25 | -158.6% | -98.4% | ||
| Q2 25 | -198.2% | -78.1% | ||
| Q1 25 | -141.7% | -137.8% | ||
| Q4 24 | -133.5% | -18.3% | ||
| Q3 24 | -84.0% | -40.8% | ||
| Q2 24 | -87.1% | -55.6% | ||
| Q1 24 | -80.8% | -52.2% |
| Q4 25 | -197.0% | -36.7% | ||
| Q3 25 | -349.3% | -85.8% | ||
| Q2 25 | -319.9% | -68.1% | ||
| Q1 25 | -143.5% | -127.9% | ||
| Q4 24 | -134.4% | -13.2% | ||
| Q3 24 | -85.1% | -32.2% | ||
| Q2 24 | -88.0% | -43.8% | ||
| Q1 24 | -81.5% | -40.1% |
| Q4 25 | $-3.59 | $-0.03 | ||
| Q3 25 | $-4.74 | $-0.05 | ||
| Q2 25 | $-0.17 | $-0.05 | ||
| Q1 25 | $-0.16 | $-0.10 | ||
| Q4 24 | $-17.27 | $-0.03 | ||
| Q3 24 | $-4.84 | $-0.04 | ||
| Q2 24 | $-0.19 | $-0.05 | ||
| Q1 24 | $-0.20 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $13.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $18.6M |
| Total Assets | $11.0M | $20.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $13.3M | ||
| Q3 25 | $7.7M | $13.5M | ||
| Q2 25 | $802.8K | $15.5M | ||
| Q1 25 | $444.7K | $16.1M | ||
| Q4 24 | $1.1M | $16.4M | ||
| Q3 24 | $756.6K | $16.7M | ||
| Q2 24 | $801.3K | $18.9M | ||
| Q1 24 | $2.5M | $19.9M |
| Q4 25 | $7.3M | $18.6M | ||
| Q3 25 | $8.9M | $19.3M | ||
| Q2 25 | $-2.1M | $20.4M | ||
| Q1 25 | $1.4M | $21.5M | ||
| Q4 24 | $2.6M | $23.9M | ||
| Q3 24 | $3.1M | $24.4M | ||
| Q2 24 | $3.4M | $25.3M | ||
| Q1 24 | $5.3M | $26.2M |
| Q4 25 | $11.0M | $20.1M | ||
| Q3 25 | $11.5M | $20.7M | ||
| Q2 25 | $4.8M | $23.3M | ||
| Q1 25 | $5.5M | $23.5M | ||
| Q4 24 | $6.5M | $26.4M | ||
| Q3 24 | $6.6M | $26.6M | ||
| Q2 24 | $6.7M | $28.5M | ||
| Q1 24 | $8.0M | $29.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $-228.0K |
| Free Cash FlowOCF − Capex | $-2.6M | — |
| FCF MarginFCF / Revenue | -160.7% | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.6M | $-228.0K | ||
| Q3 25 | $-2.5M | $-2.0M | ||
| Q2 25 | $-2.6M | $-514.0K | ||
| Q1 25 | $-1.6M | $-391.0K | ||
| Q4 24 | $-1.7M | $-293.0K | ||
| Q3 24 | $-1.7M | $-2.1M | ||
| Q2 24 | $-1.5M | $-840.0K | ||
| Q1 24 | $-2.3M | $-2.2M |
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.7M | $-301.0K | ||
| Q3 24 | $-1.7M | $-2.1M | ||
| Q2 24 | $-1.6M | $-1.0M | ||
| Q1 24 | $-2.4M | $-2.3M |
| Q4 25 | -160.7% | — | ||
| Q3 25 | -171.8% | — | ||
| Q2 25 | -209.6% | — | ||
| Q1 25 | -91.3% | — | ||
| Q4 24 | -76.0% | -7.5% | ||
| Q3 24 | -73.1% | -77.8% | ||
| Q2 24 | -65.1% | -46.4% | ||
| Q1 24 | -99.2% | -102.3% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 2.7% | 0.0% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.4% | 0.3% | ||
| Q2 24 | 1.2% | 8.2% | ||
| Q1 24 | 1.7% | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIAF
Segment breakdown not available.
MSN
| Products | $1.8M | 95% |
| Other | $87.0K | 5% |
